Differential regulation of glucose transporter 1 and 2 mRNA expression by epidermal growth factor and transforming growth factor-beta in rat hepatocytesMISCHOULON, D; RANA, B; KOTLIAR, N et al.Journal of cellular physiology. 1992, Vol 153, Num 2, pp 288-296, issn 0021-9541Article

The potential relationship between levels of perceived stress and subtypes of major depressive disorder (MDD)FARABAUGH, A. H; MISCHOULON, D; FAVA, M et al.Acta psychiatrica Scandinavica. 2004, Vol 110, Num 6, pp 465-470, issn 0001-690X, 6 p.Article

Nutrition and depression : Focus on folateALPERT, J. E; MISCHOULON, D; NIERENBERG, A. A et al.Nutrition (Burbank, Los Angeles County, Calif.). 2000, Vol 16, Num 7-8, pp 544-546, issn 0899-9007Article

Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorderLEVKOVITZ, Y; ALPERT, J. E; BRINTZ, C. E et al.European psychiatry. 2012, Vol 27, Num 7, pp 518-521, issn 0924-9338, 4 p.Article

Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBPα) gene expression during hepatocyte proliferation in the regenerating liver and in cultureMISCHOULON, D; RANA, B; BUCHER, N. L. R et al.Molecular and cellular biology (Print). 1992, Vol 12, Num 6, pp 2553-2560, issn 0270-7306Article

SAMe and sexual functioningDORDING, C. M; MISCHOULON, D; SHYU, I et al.European psychiatry. 2012, Vol 27, Num 6, pp 451-454, issn 0924-9338, 4 p.Article

Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/dayPERLIS, R. H; ALPERT, J; NIERENBERG, A. A et al.Acta psychiatrica Scandinavica. 2003, Vol 108, Num 6, pp 432-438, issn 0001-690X, 7 p.Article

Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment : A survey of cliniciansMISCHOULON, D; NIERENBERG, A. A; KIZILBASH, L et al.Canadian journal of psychiatry. 2000, Vol 45, Num 5, pp 476-481, issn 0706-7437Article